Zhejiang Hisoar Pharmaceutical Co Ltd Asset Resilience Ratio
Zhejiang Hisoar Pharmaceutical Co Ltd asset resilience ratio. Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has an Asset Resilience Ratio of 0.20% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Zhejiang Hisoar Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Asset resilience ratio of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. This chart shows how Zhejiang Hisoar Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Zhejiang Hisoar Pharmaceutical Co Ltd (002099) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Hisoar Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Zhejiang Hisoar Pharmaceutical Co Ltd assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥14.71 Million | 0.2% |
| Total Liquid Assets | CN¥14.71 Million | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Hisoar Pharmaceutical Co Ltd maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Hisoar Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Hisoar Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Zhejiang Hisoar Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2003–2024)
Zhejiang Hisoar Pharmaceutical Co Ltd asset resilience ratio by year from 2003 to 2024. The table below shows the annual Asset Resilience Ratio data for Zhejiang Hisoar Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.60% | CN¥45.03 Million ≈ $6.59 Million |
CN¥7.46 Billion ≈ $1.09 Billion |
+0.49pp |
| 2021-12-31 | 0.12% | CN¥9.48 Million ≈ $1.39 Million |
CN¥8.02 Billion ≈ $1.17 Billion |
-2.01pp |
| 2018-12-31 | 2.13% | CN¥150.00 Million ≈ $21.95 Million |
CN¥7.04 Billion ≈ $1.03 Billion |
+1.46pp |
| 2017-12-31 | 0.67% | CN¥50.00 Million ≈ $7.32 Million |
CN¥7.47 Billion ≈ $1.09 Billion |
+0.67pp |
| 2014-12-31 | 0.00% | CN¥119.75K ≈ $17.52K |
CN¥4.17 Billion ≈ $609.83 Million |
-0.04pp |
| 2011-12-31 | 0.04% | CN¥561.04K ≈ $82.10K |
CN¥1.44 Billion ≈ $210.01 Million |
-0.02pp |
| 2006-12-31 | 0.05% | CN¥500.00K ≈ $73.17K |
CN¥921.93 Million ≈ $134.91 Million |
-0.08pp |
| 2005-12-31 | 0.14% | CN¥800.00K ≈ $117.07K |
CN¥576.72 Million ≈ $84.39 Million |
-0.01pp |
| 2004-12-31 | 0.15% | CN¥576.32K ≈ $84.33K |
CN¥387.38 Million ≈ $56.69 Million |
-1.14pp |
| 2003-12-31 | 1.29% | CN¥4.67 Million ≈ $683.58K |
CN¥362.38 Million ≈ $53.03 Million |
-- |
About Zhejiang Hisoar Pharmaceutical Co Ltd
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical… Read more